(Q69448180)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2625445%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

title

Reversed-phase liquid chromatographic retention and selectivity surfaces. II. Deoxyribonucleosides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2625445%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

author name string

E Grushka

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2625445%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

N I Jang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2625445%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

P R Brown

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2625445%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

publication date

1 December 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2625445%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

volume

485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2625445%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

page(s)

617-630

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2625445%20AND%20SRC:MED&resulttype=core&format=json

The purine path to chemotherapy

2 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2989168-8

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2989168-8

2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2989168-8

3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2989168-8

Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2989168-8

Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2989168-8

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2989168-8

Treatment of human immunodeficiency virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2989168-8

Retention and selectivity surfaces of deoxyribonucleotides in reversed-phase chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2989168-8

Optimization by isochronal analysis. II. Changes in mobile phase velocity and temperature, and in mobile phase composition and temperature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2989168-8

10.1016/S0021-9673(01)89168-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2625445%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

1 reference